Managbanag, Roberto .

HRN: 29-06-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/24/2026
05/31/2026
IV
2.25G
Q8H
UROSEPSIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines